{
  "ptid_time": "094_S_4737_2012-06-08",
  "img_path": "/data/qiuhui/data/adni/images/094_S_4737/2012-06-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 43,747 mm³, 55.9% above the reference mean. With a Z-score of 1.28 (90.0th percentile), this represents mild enlargement; hippocampal volume measures 5,648 mm³, 20.6% below the reference mean. With a Z-score of -1.89 (2.9th percentile), this represents moderate atrophy; whole brain volume measures 883,897 mm³, 9.3% below the reference mean. With a Z-score of -1.17 (12.1th percentile), this represents mild atrophy. ",
  "text_data": "Age is 74.3 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Cardiovascular; Endocrine-Metabolic. MMSE: 23.0. MoCA: 20.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.14 SUVR (normal ); Amyloid beta: 611.80 pg/mL (mild reduced); Total tau: 294.60 pg/mL (normal ); Phosphorylated tau: 26.50 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows moderate hippocampal atrophy (Z-score -1.89, 2.9th percentile) and mild whole-brain atrophy (Z-score -1.17, 12.1th percentile), along with mild ventricular enlargement (Z-score 1.28, 90th percentile). Cognitive testing (MMSE 23, MoCA 20) indicates mild impairment, while biomarkers (Aβ mildly reduced, normal tau, normal AV45) suggest early Alzheimer's pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's disease)  \n**Confidence:** **Medium** (cognitive scores and imaging support MCI, but biomarker profile is not strongly definitive for AD)",
  "timestamp": "2025-07-26T10:33:54.666382"
}